aluates Reports

$ 0.0

Automative

Hepatitis A Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-22O67

Global Hepatitis A Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

BUY CHAPTERS

Hepatitis A Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-22O67

Report

August 2025

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

Convac

KM Biologics

Imbcams

Hepatitis A Vaccine- Market Size

The global market for Hepatitis A Vaccine was estimated to be worth US$ 751 million in 2024 and is forecast to a readjusted size of US$ 875 million by 2031 with a CAGR of 2.2% during the forecast period 2025-2031.

Hepatitis A Vaccine- Market

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.

Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%. In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.

This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hepatitis A Vaccine by region & country, by Type, and by Application.

The Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine.

Market Segmentation

Scope of Hepatitis A Vaccine- Market Report

Report Metric	Details
Report Name	Hepatitis A Vaccine- Market
Forecasted market size in 2031	US$ 875 million
CAGR	2.2%
Forecasted years	2025 - 2031
Segment by Type	Inactivated Vaccine Live Attenuated Vaccine
Segment by Application	Government Institution Private Sector Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hepatitis A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hepatitis A Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Hepatitis A Vaccine- Market size in 2031?

Ans: The Hepatitis A Vaccine- Market size in 2031 will be US$ 875 million.

What is the market share of major companies in Hepatitis A Vaccine- Market?

Ans: Global top 5 manufacturers hold a share over 80%.

What is the Hepatitis A Vaccine- Market share by type?

Ans: In terms of product, inactivated vaccine is the largest segment, with a share about 85%.

Who are the main players in the Hepatitis A Vaccine- Market report?

Ans: The main players in the Hepatitis A Vaccine- Market are GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac

What are the Application segmentation covered in the Hepatitis A Vaccine- Market report?

Ans: The Applications covered in the Hepatitis A Vaccine- Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Hepatitis A Vaccine- Market report?

Ans: The Types covered in the Hepatitis A Vaccine- Market report are Inactivated Vaccine, Live Attenuated Vaccine

1 Market Overview

1.1 Hepatitis A Vaccine Product Introduction

1.2 Global Hepatitis A Vaccine Market Size Forecast

1.2.1 Global Hepatitis A Vaccine Sales Value (2020-2031)

1.2.2 Global Hepatitis A Vaccine Sales Volume (2020-2031)

1.2.3 Global Hepatitis A Vaccine Sales Price (2020-2031)

1.3 Hepatitis A Vaccine Market Trends & Drivers

1.3.1 Hepatitis A Vaccine Industry Trends

1.3.2 Hepatitis A Vaccine Market Drivers & Opportunity

1.3.3 Hepatitis A Vaccine Market Challenges

1.3.4 Hepatitis A Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hepatitis A Vaccine Players Revenue Ranking (2024)

2.2 Global Hepatitis A Vaccine Revenue by Company (2020-2025)

2.3 Global Hepatitis A Vaccine Players Sales Volume Ranking (2024)

2.4 Global Hepatitis A Vaccine Sales Volume by Company Players (2020-2025)

2.5 Global Hepatitis A Vaccine Average Price by Company (2020-2025)

2.6 Key Manufacturers Hepatitis A Vaccine Manufacturing Base and Headquarters

2.7 Key Manufacturers Hepatitis A Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Hepatitis A Vaccine

2.9 Hepatitis A Vaccine Market Competitive Analysis

2.9.1 Hepatitis A Vaccine Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Hepatitis A Vaccine Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Inactivated Vaccine

3.1.2 Live Attenuated Vaccine

3.2 Global Hepatitis A Vaccine Sales Value by Type

3.2.1 Global Hepatitis A Vaccine Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Hepatitis A Vaccine Sales Value, by Type (2020-2031)

3.2.3 Global Hepatitis A Vaccine Sales Value, by Type (%) (2020-2031)

3.3 Global Hepatitis A Vaccine Sales Volume by Type

3.3.1 Global Hepatitis A Vaccine Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Hepatitis A Vaccine Sales Volume, by Type (2020-2031)

3.3.3 Global Hepatitis A Vaccine Sales Volume, by Type (%) (2020-2031)

3.4 Global Hepatitis A Vaccine Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Government Institution

4.1.2 Private Sector

4.1.3 Other

4.2 Global Hepatitis A Vaccine Sales Value by Application

4.2.1 Global Hepatitis A Vaccine Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Hepatitis A Vaccine Sales Value, by Application (2020-2031)

4.2.3 Global Hepatitis A Vaccine Sales Value, by Application (%) (2020-2031)

4.3 Global Hepatitis A Vaccine Sales Volume by Application

4.3.1 Global Hepatitis A Vaccine Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Hepatitis A Vaccine Sales Volume, by Application (2020-2031)

4.3.3 Global Hepatitis A Vaccine Sales Volume, by Application (%) (2020-2031)

4.4 Global Hepatitis A Vaccine Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Hepatitis A Vaccine Sales Value by Region

5.1.1 Global Hepatitis A Vaccine Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Hepatitis A Vaccine Sales Value by Region (2020-2025)

5.1.3 Global Hepatitis A Vaccine Sales Value by Region (2026-2031)

5.1.4 Global Hepatitis A Vaccine Sales Value by Region (%), (2020-2031)

5.2 Global Hepatitis A Vaccine Sales Volume by Region

5.2.1 Global Hepatitis A Vaccine Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Hepatitis A Vaccine Sales Volume by Region (2020-2025)

5.2.3 Global Hepatitis A Vaccine Sales Volume by Region (2026-2031)

5.2.4 Global Hepatitis A Vaccine Sales Volume by Region (%), (2020-2031)

5.3 Global Hepatitis A Vaccine Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Hepatitis A Vaccine Sales Value, 2020-2031

5.4.2 North America Hepatitis A Vaccine Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Hepatitis A Vaccine Sales Value, 2020-2031

5.5.2 Europe Hepatitis A Vaccine Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Hepatitis A Vaccine Sales Value, 2020-2031

5.6.2 Asia Pacific Hepatitis A Vaccine Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Hepatitis A Vaccine Sales Value, 2020-2031

5.7.2 South America Hepatitis A Vaccine Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Hepatitis A Vaccine Sales Value, 2020-2031

5.8.2 Middle East & Africa Hepatitis A Vaccine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hepatitis A Vaccine Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Hepatitis A Vaccine Sales Value

6.2.1 Key Countries/Regions Hepatitis A Vaccine Sales Value, 2020-2031

6.2.2 Key Countries/Regions Hepatitis A Vaccine Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Hepatitis A Vaccine Sales Value, 2020-2031

6.3.2 United States Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Hepatitis A Vaccine Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Hepatitis A Vaccine Sales Value, 2020-2031

6.4.2 Europe Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Hepatitis A Vaccine Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Hepatitis A Vaccine Sales Value, 2020-2031

6.5.2 China Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

6.5.3 China Hepatitis A Vaccine Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Hepatitis A Vaccine Sales Value, 2020-2031

6.6.2 Japan Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Hepatitis A Vaccine Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Hepatitis A Vaccine Sales Value, 2020-2031

6.7.2 South Korea Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Hepatitis A Vaccine Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Hepatitis A Vaccine Sales Value, 2020-2031

6.8.2 Southeast Asia Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Hepatitis A Vaccine Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Hepatitis A Vaccine Sales Value, 2020-2031

6.9.2 India Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

6.9.3 India Hepatitis A Vaccine Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 GSK

7.1.1 GSK Company Information

7.1.2 GSK Introduction and Business Overview

7.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 GSK Hepatitis A Vaccine Product Offerings

7.1.5 GSK Recent Development

7.2 Merck

7.2.1 Merck Company Information

7.2.2 Merck Introduction and Business Overview

7.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Merck Hepatitis A Vaccine Product Offerings

7.2.5 Merck Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Sanofi Hepatitis A Vaccine Product Offerings

7.3.5 Sanofi Recent Development

7.4 Sinovac

7.4.1 Sinovac Company Information

7.4.2 Sinovac Introduction and Business Overview

7.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Sinovac Hepatitis A Vaccine Product Offerings

7.4.5 Sinovac Recent Development

7.5 Zhejiang Pukang

7.5.1 Zhejiang Pukang Company Information

7.5.2 Zhejiang Pukang Introduction and Business Overview

7.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Offerings

7.5.5 Zhejiang Pukang Recent Development

7.6 Changchun Institute of Biological

7.6.1 Changchun Institute of Biological Company Information

7.6.2 Changchun Institute of Biological Introduction and Business Overview

7.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Offerings

7.6.5 Changchun Institute of Biological Recent Development

7.7 KM Biologics

7.7.1 KM Biologics Company Information

7.7.2 KM Biologics Introduction and Business Overview

7.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 KM Biologics Hepatitis A Vaccine Product Offerings

7.7.5 KM Biologics Recent Development

7.8 IMBCAMS

7.8.1 IMBCAMS Company Information

7.8.2 IMBCAMS Introduction and Business Overview

7.8.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 IMBCAMS Hepatitis A Vaccine Product Offerings

7.8.5 IMBCAMS Recent Development

7.9 Convac

7.9.1 Convac Company Information

7.9.2 Convac Introduction and Business Overview

7.9.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Convac Hepatitis A Vaccine Product Offerings

7.9.5 Convac Recent Development

8 Industry Chain Analysis

8.1 Hepatitis A Vaccine Industrial Chain

8.2 Hepatitis A Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hepatitis A Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Hepatitis A Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

Convac

KM Biologics

Imbcams

List of Tables

Table 1. Hepatitis A Vaccine Market Trends

Table 2. Hepatitis A Vaccine Market Drivers & Opportunity

Table 3. Hepatitis A Vaccine Market Challenges

Table 4. Hepatitis A Vaccine Market Restraints

Table 5. Global Hepatitis A Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Hepatitis A Vaccine Revenue Market Share by Company (2020-2025)

Table 7. Global Hepatitis A Vaccine Sales Volume by Company (2020-2025) & (K Unit)

Table 8. Global Hepatitis A Vaccine Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Hepatitis A Vaccine Price by Company (2020-2025) & (USD/Unit)

Table 10. Key Manufacturers Hepatitis A Vaccine Manufacturing Base and Headquarters

Table 11. Key Manufacturers Hepatitis A Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Hepatitis A Vaccine

Table 13. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Hepatitis A Vaccine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Hepatitis A Vaccine Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Hepatitis A Vaccine Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Hepatitis A Vaccine Sales Market Share in Value by Type (2020-2025)

Table 20. Global Hepatitis A Vaccine Sales Market Share in Value by Type (2026-2031)

Table 21. Global Hepatitis A Vaccine Sales Volume by Type: 2020 VS 2024 VS 2031 (K Unit)

Table 22. Global Hepatitis A Vaccine Sales Volume by Type (2020-2025) & (K Unit)

Table 23. Global Hepatitis A Vaccine Sales Volume by Type (2026-2031) & (K Unit)

Table 24. Global Hepatitis A Vaccine Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Hepatitis A Vaccine Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Hepatitis A Vaccine Price by Type (2020-2025) & (USD/Unit)

Table 27. Global Hepatitis A Vaccine Price by Type (2026-2031) & (USD/Unit)

Table 28. Global Hepatitis A Vaccine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Hepatitis A Vaccine Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Hepatitis A Vaccine Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Hepatitis A Vaccine Sales Market Share in Value by Application (2020-2025)

Table 32. Global Hepatitis A Vaccine Sales Market Share in Value by Application (2026-2031)

Table 33. Global Hepatitis A Vaccine Sales Volume by Application: 2020 VS 2024 VS 2031 (K Unit)

Table 34. Global Hepatitis A Vaccine Sales Volume by Application (2020-2025) & (K Unit)

Table 35. Global Hepatitis A Vaccine Sales Volume by Application (2026-2031) & (K Unit)

Table 36. Global Hepatitis A Vaccine Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Hepatitis A Vaccine Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Hepatitis A Vaccine Price by Application (2020-2025) & (USD/Unit)

Table 39. Global Hepatitis A Vaccine Price by Application (2026-2031) & (USD/Unit)

Table 40. Global Hepatitis A Vaccine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Hepatitis A Vaccine Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Hepatitis A Vaccine Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Hepatitis A Vaccine Sales Value by Region (2020-2025) & (%)

Table 44. Global Hepatitis A Vaccine Sales Value by Region (2026-2031) & (%)

Table 45. Global Hepatitis A Vaccine Sales Volume by Region (K Unit): 2020 VS 2024 VS 2031

Table 46. Global Hepatitis A Vaccine Sales Volume by Region (2020-2025) & (K Unit)

Table 47. Global Hepatitis A Vaccine Sales Volume by Region (2026-2031) & (K Unit)

Table 48. Global Hepatitis A Vaccine Sales Volume by Region (2020-2025) & (%)

Table 49. Global Hepatitis A Vaccine Sales Volume by Region (2026-2031) & (%)

Table 50. Global Hepatitis A Vaccine Average Price by Region (2020-2025) & (USD/Unit)

Table 51. Global Hepatitis A Vaccine Average Price by Region (2026-2031) & (USD/Unit)

Table 52. Key Countries/Regions Hepatitis A Vaccine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Hepatitis A Vaccine Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Hepatitis A Vaccine Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Hepatitis A Vaccine Sales Volume, (2020-2025) & (K Unit)

Table 56. Key Countries/Regions Hepatitis A Vaccine Sales Volume, (2026-2031) & (K Unit)

Table 57. GSK Company Information

Table 58. GSK Introduction and Business Overview

Table 59. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 60. GSK Hepatitis A Vaccine Product Offerings

Table 61. GSK Recent Development

Table 62. Merck Company Information

Table 63. Merck Introduction and Business Overview

Table 64. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 65. Merck Hepatitis A Vaccine Product Offerings

Table 66. Merck Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 70. Sanofi Hepatitis A Vaccine Product Offerings

Table 71. Sanofi Recent Development

Table 72. Sinovac Company Information

Table 73. Sinovac Introduction and Business Overview

Table 74. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 75. Sinovac Hepatitis A Vaccine Product Offerings

Table 76. Sinovac Recent Development

Table 77. Zhejiang Pukang Company Information

Table 78. Zhejiang Pukang Introduction and Business Overview

Table 79. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Zhejiang Pukang Hepatitis A Vaccine Product Offerings

Table 81. Zhejiang Pukang Recent Development

Table 82. Changchun Institute of Biological Company Information

Table 83. Changchun Institute of Biological Introduction and Business Overview

Table 84. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 85. Changchun Institute of Biological Hepatitis A Vaccine Product Offerings

Table 86. Changchun Institute of Biological Recent Development

Table 87. KM Biologics Company Information

Table 88. KM Biologics Introduction and Business Overview

Table 89. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 90. KM Biologics Hepatitis A Vaccine Product Offerings

Table 91. KM Biologics Recent Development

Table 92. IMBCAMS Company Information

Table 93. IMBCAMS Introduction and Business Overview

Table 94. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 95. IMBCAMS Hepatitis A Vaccine Product Offerings

Table 96. IMBCAMS Recent Development

Table 97. Convac Company Information

Table 98. Convac Introduction and Business Overview

Table 99. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 100. Convac Hepatitis A Vaccine Product Offerings

Table 101. Convac Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Hepatitis A Vaccine Downstream Customers

Table 105. Hepatitis A Vaccine Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Hepatitis A Vaccine Product Picture

Figure 2. Global Hepatitis A Vaccine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Hepatitis A Vaccine Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Hepatitis A Vaccine Sales Volume (2020-2031) & (K Unit)

Figure 5. Global Hepatitis A Vaccine Sales Price (2020-2031) & (USD/Unit)

Figure 6. Hepatitis A Vaccine Report Years Considered

Figure 7. Global Hepatitis A Vaccine Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Hepatitis A Vaccine Players Sales Volume Ranking (2024) & (K Unit)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hepatitis A Vaccine Revenue in 2024

Figure 10. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Inactivated Vaccine Picture

Figure 12. Live Attenuated Vaccine Picture

Figure 13. Global Hepatitis A Vaccine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Hepatitis A Vaccine Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Hepatitis A Vaccine Sales Volume by Type (2020 VS 2024 VS 2031) & (K Unit)

Figure 16. Global Hepatitis A Vaccine Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Hepatitis A Vaccine Price by Type (2020-2031) & (USD/Unit)

Figure 18. Product Picture of Government Institution

Figure 19. Product Picture of Private Sector

Figure 20. Product Picture of Other

Figure 21. Global Hepatitis A Vaccine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Hepatitis A Vaccine Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Hepatitis A Vaccine Sales Volume by Application (2020 VS 2024 VS 2031) & (K Unit)

Figure 24. Global Hepatitis A Vaccine Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Hepatitis A Vaccine Price by Application (2020-2031) & (USD/Unit)

Figure 26. North America Hepatitis A Vaccine Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Hepatitis A Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Hepatitis A Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Hepatitis A Vaccine Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Hepatitis A Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Hepatitis A Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Hepatitis A Vaccine Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Hepatitis A Vaccine Sales Volume (%), (2020-2031)

Figure 38. United States Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Hepatitis A Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Hepatitis A Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 44. China Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 46. China Hepatitis A Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Hepatitis A Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Hepatitis A Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Hepatitis A Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 56. India Hepatitis A Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Hepatitis A Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 58. India Hepatitis A Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 59. Hepatitis A Vaccine Industrial Chain

Figure 60. Hepatitis A Vaccine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Mono Hepatitis A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Hepatitis A Vaccine Market Research Report 2024

Global Hepatitis A and B Vaccine Market Research Report 2025

Global Hepatitis A and B Vaccination Market Research Report 2025

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis B Vaccination Market Research Report 2025

Hepatitis B Vaccines Market

Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis A immunoglobulin Market Research Report 2025

Mono Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis A Virus HAV Rapid Test Kit Market Research Report 2024

Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adult Preventable Vaccines Market Research Report 2024

Global Recombinant Hamster Ovary Cell CHO Hepatitis B Vaccine Market Insights Forecast to 2030

Global Travel Vaccines Market Insights Forecast to 2030

Global Adult and Pediatric Vaccines Market Research Report 2024

Global Human Injection Flu Vaccine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions